VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tunica Albuginea who wrote (4561)	1/15/1998 2:30:00 AM
From: BigKNY3	Read Replies (1) of 23519

TA: <<.The studies as I read them indicate the CONTINUED NEED FOR stimulation for 1/2 to 1 hour in order to have enough vasodilating Nitrous oxide produced;>> TA: Please provide your reference source. I have never read this statement anywhere. As long as it is effective and safe,I believe ED patients will adapt to administering Viagra depending on their own habits and onset of action. The real future market for MUSE will be non-responders to oral meds and patients where combination therapy is appropriate. This could represent a potential 20-35% of an expanding total ED market. BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next